Camber Spine has announced that it has received a notice of allowance from the US Patent and Trademark Office (USPTO) for its Spira Lateral 3.0 interbody fusion implant.
Camber Spine state that as part of the Spira product platform, the Spira Lateral 3.0 implant is a titanium open architecture LLIF utilising Camber’s Surface by Design technology to optimise bone growth. It provides surgeons with a new design configuration based on the Spira platform to be utilised in unilateral posterior lumbar interbody fusion procedures.
A company press release noted that the Lateral 3.0’s open architecture and arched design includes large openings for significant graft packing. It also decreases the risk of subsidence due to the design’s “snowshoe effect” and provides good visibility for fusion.
According to the company, with Spira implants, newly forming bone grows onto and through the multiple roughened titanium arches to achieve maximum stability and complete endplate-to-endplate arthrodesis. They further state that Spira implants also enable easy insertion with smooth leading edges and pockets that interlock with the inserter to provide rotational stability.